SNDA Stock Analysis: Sonida Senior Living | NYSE
Medical Care Facilities | NYSE, USA | Market Cap: 1.806m USD | 12M Return: 49.6% | US1404752032 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 18.2M
Qual. Beats: 0
Rev. Trend: 97.4%
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sonida Senior Living, Inc. (NYSE: SNDA) is a Dallas-based operator of senior housing communities in the United States, founded in 1990 and previously known as Capital Senior Living Corporation until its November 2021 rebranding. The company generates revenue from three primary service lines: independent living, which bundles housing with meals, housekeeping, transportation, recreational activities, and 24-hour staffing; assisted living, which adds personal care support such as help with bathing, dressing, grooming, and medication management; and memory care, which serves residents with dementia and related conditions. Sonida also supplements its offering with respite care, short-stay programs, and third-party home care services covering physician, dental, podiatry, and therapy visits.
The senior housing industry is generally classified within the healthcare sector, with operators typically earning revenue through a combination of monthly resident fees, entrance or community fees, and ancillary service charges. Senior living providers like Sonida operate within a continuum-of-care model, meaning residents can transition between independent living, assisted living, and memory care as their needs change, which is intended to support longer tenancies and recurring monthly revenue streams. Demand for these services is driven primarily by demographic aging, particularly the growth of the population aged 75 and older.
- Senior housing occupancy recovery drives same-store revenue growth
- Labor cost inflation pressures assisted living operating margins
- Rising interest expense from refinanced debt weighs on earnings
| Net Income: -122.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 0.05 > 1.0 |
| NWC/Revenue: -2.84% < 20% (prev -3.16%; Δ 0.32% < -1%) |
| CFO/TA -0.01 > 3% & CFO -15.6m > Net Income -122.4m |
| Net Debt (1.53b) to EBITDA (25.3m): 60.37 < 3 |
| Current Ratio: 0.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.1m) vs 12m ago 0.07% < -2% |
| Gross Margin: -15.77% > 18% (prev 96.62%; Δ -112.4% > 0.5%) |
| Asset Turnover: 30.95% > 50% (prev 41.44%; Δ -10.48% > 0%) |
| Interest Coverage Ratio: -1.21 > 6 (EBIT TTM -67.3m / Interest Expense TTM 55.7m) |
| A: -0.01 (Total Current Assets 110.4m - Total Current Liabilities 125.4m) / Total Assets 2.55b |
| B: -0.22 (Retained Earnings -556.7m / Total Assets 2.55b) |
| C: -0.04 (EBIT TTM -67.3m / Avg Total Assets 1.70b) |
| D: 0.51 (Book Value of Equity 861.6m / Total Liabilities 1.68b) |
| Altman-Z'' = -0.48 = B |
| DSRI: 0.68 (Receivables 23.7m/23.2m, Revenue 526.0m/352.1m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 2.31 (AQ_t 0.10 / AQ_t-1 0.04) |
| SGI: 1.49 (Revenue 526.0m / 352.1m) |
| TATA: -0.04 (NI -122.4m - CFO -15.6m) / TA 2.55b) |
| Beneish M = -2.16 (Cap -4..+1) = BB |
As of September 04, 2026, the stock is trading at USD 37.88 with a total of 522,421 shares traded. Over the past week, the price has changed by -2.87%, over one month by -5.82%, over three months by +12.67% and over the past year by +49.61%.
Current recommended Stop Loss: 34.40 (which is 9.2% or 2.2 ATR below the current price).
Sonida Senior Living has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold SNDA.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 48.5 | 28% |
P/E Forward = 59.8802
P/S = 3.7534
P/B = 2.108
P/EG = 2.0444
Revenue TTM = 526.0m USD
EBIT TTM = -67.3m USD
EBITDA TTM = 25.3m USD
Long Term Debt = 682.5m USD (from longTermDebt, last fiscal year)
Short Term Debt = 16.1m USD (from shortTermDebt, last quarter)
Debt = 1.57b USD (from shortLongTermDebtTotal, last quarter) + Leases 566k
Net Debt = 1.53b USD (calculated: Debt 1.57b - CCE 48.7m)
Enterprise Value = 3.33b USD (1.81b + Debt 1.57b - CCE 48.7m)
Interest Coverage Ratio = -1.21 (Ebit TTM -67.3m / Interest Expense TTM 55.7m)
EV/FCF = -63.19x (Enterprise Value 3.33b / FCF TTM -52.7m)
FCF Yield = -1.58% (FCF TTM -52.7m / Enterprise Value 3.33b)
FCF Margin = -10.02% (FCF TTM -52.7m / Revenue TTM 526.0m)
Net Margin = -23.27% (Net Income TTM -122.4m / Revenue TTM 526.0m)
Gross Margin = -15.77% ((Revenue TTM 526.0m - Cost of Revenue TTM 608.9m) / Revenue TTM)
Gross Margin QoQ = 29.71% (prev -10.09%)
Tobins Q-Ratio = 1.31 (Enterprise Value 3.33b / Total Assets 2.55b)
Interest Expense / Debt = 3.54% (Interest Expense 55.7m / Debt 1.57b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -53.2m (EBIT -67.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.88 (Total Current Assets 110.4m / Total Current Liabilities 125.4m)
Debt / Equity = 1.83 (Debt 1.57b / totalStockholderEquity, last quarter 861.6m)
Debt / EBITDA = 60.37 (Net Debt 1.53b / EBITDA 25.3m)
Debt / FCF = -28.94 (negative FCF - burning cash) (Net Debt 1.53b / FCF TTM -52.7m)
Total Stockholder Equity = 469.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -7.20% (Net Income -122.4m / Total Assets 2.55b)
RoE = -26.06% (Net Income TTM -122.4m / Total Stockholder Equity 469.7m)
RoCE = -5.84% (EBIT -67.3m / Capital Employed (Equity 469.7m + L.T.Debt 682.5m))
RoIC = -2.20% (negative operating profit) (NOPAT -53.2m / Invested Capital 2.41b)
WACC = 5.29% (E(1.81b)/V(3.38b) * Re(7.46%) + D(1.57b)/V(3.38b) * Rd(3.54%) * (1-Tc(0.21)))
Discount Rate = 7.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 79.22 | Cagr: 27.07%
[DCF] Fair Price = unknown (Cash Flow -52.7m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.72 | # QB: 0
Revenue Correlation: 97.45 | Revenue CAGR: 29.50% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=-3.59 | Chg30d=-19.67% | Revisions=-25% | GrowthEPS=+14.9% | GrowthRev=+94.5%
EPS next Year (2027-12-31): EPS=-1.65 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+74.2% | GrowthRev=+17.5%
[Analyst] Revisions Ratio: -25% (up=0, down=1)